ExploreWatchlistsPricing
  1. US-listed companies
  2. PTC THERAPEUTICS, INC.
  3. Financials
  4. Research & development

PTC THERAPEUTICS, INC. (PTCT)

Market cap
$5.9B
P/E ratio
9.2x
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 2025455-14.82%
Dec 31, 2024534-19.82%
Dec 31, 2023667+2.31%
Dec 31, 2022651+20.49%
Dec 31, 2021541+13.20%
Dec 31, 2020478+85.53%
Dec 31, 2019257+49.70%
Dec 31, 2018172+46.42%
Dec 31, 2017117-0.15%
Dec 31, 2016118-3.43%
Dec 31, 2015122+52.58%
Dec 31, 201480+45.49%
Dec 31, 201355

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat